Ligand ID: WJZ


Drugbank ID:
DB06823
(Tiopronin)


Indication:
Tiopronin is indicated for the prevention of kidney stone formation in patients with severe homozygous cystinuria consisting of a urinary cystine concentration greater than 500 mg/day, and who have failed treatment with non-pharmacological measures of increased fluid intake, decreased sodium and protein intake, and urine alkalinization.

Get human targets for WJZ in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND 'WJZ' AND SARS-COV-2 / COVID-19 STRUCTURES

1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera throuh AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 View Interface RMSD Seq.
Identity (%)		 HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		5r84 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 8
VAL A  36
HIS A  80
CYH A  22
ASN A  63
1.72A19.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
HIS A  41
CYH A 145
GLY A 174
HIS A 163
1.51A18.18
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		6lze VIRAL PROTEASE
(SARS-CoV-2)		4 / 7
HIS A  41
CYH A 145
GLY A 174
HIS A 163
1.51A20.06
ALC  D   2 ( 4.1A)
ELL  D   3 (-1.7A)
None
ELL  D   3 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		6m0k VIRAL PROTEASE
(SARS-CoV-2)		4 / 7
HIS A  41
CYH A 145
GLY A 174
HIS A 163
1.54A20.00
N0A  D   2 ( 4.0A)
ELL  D   3 (-1.8A)
None
ELL  D   3 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		6m2q 3CL PROTEASE
(SARS-CoV-2)		4 / 7
HIS A  41
CYH A 145
GLY A 174
HIS A 163
1.57A19.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6vxs NSP3
(SARS-CoV-2)		4 / 8
HIS B  45
HIS B  94
ASN B  37
HIS B  86
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6vxs NSP3
(SARS-CoV-2)		4 / 8
VAL B  24
HIS B  45
HIS B  94
CYH B  92
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6vxs NSP3
(SARS-CoV-2)		4 / 8
VAL A  24
HIS A  45
HIS A  94
CYH A  92
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6vxs NSP3
(SARS-CoV-2)		4 / 8
VAL A  24
HIS A  45
HIS A  94
ASN A  37
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6vxs NSP3
(SARS-CoV-2)		4 / 8
HIS A  45
HIS A  94
ASN A  37
HIS A  86
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6vxs NSP3
(SARS-CoV-2)		4 / 8
VAL B  24
HIS B  45
HIS B  94
ASN B  37
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		6w01 URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 7
HIS B 250
CYH B 293
LYS B 290
GLY B 247
1.49A19.41
CIT  B 408 (-3.9A)
None
CIT  B 408 (-3.0A)
CIT  B 408 (-3.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6w63 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 8
VAL A  36
HIS A  80
CYH A  22
ASN A  63
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		6w63 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
HIS A  41
CYH A 145
GLY A 174
HIS A 163
1.51A19.88
X77  A 401 (-3.2A)
X77  A 401 (-3.0A)
None
X77  A 401 (-4.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		6w63 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
MET A 162
GLY A 143
ASN A  28
HIS A  41
1.73A19.88
None
X77  A 401 (-3.6A)
None
X77  A 401 (-3.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6w6y NSP3
(SARS-CoV-2)		4 / 8
HIS B  45
HIS B  94
ASN B  37
HIS B  86
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6w6y NSP3
(SARS-CoV-2)		4 / 8
VAL B  24
HIS B  45
HIS B  94
CYH B  92
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6w6y NSP3
(SARS-CoV-2)		4 / 8
VAL A  24
HIS A  45
HIS A  94
CYH A  92
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6w6y NSP3
(SARS-CoV-2)		4 / 8
VAL A  24
HIS A  45
HIS A  94
ASN A  37
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6w6y NSP3
(SARS-CoV-2)		4 / 8
HIS A  45
HIS A  94
ASN A  37
HIS A  86
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6w6y NSP3
(SARS-CoV-2)		4 / 8
VAL B  24
HIS B  45
HIS B  94
ASN B  37
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6w75 NSP16
(SARS-CoV-2)		4 / 8
VAL A6992
TRP A7029
HIS A7023
CYH A6823
1.66A19.84
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6wcf NSP3
(SARS-CoV-2)		4 / 8
VAL A  24
HIS A  45
HIS A  94
ASN A  37
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6wcf NSP3
(SARS-CoV-2)		4 / 8
HIS A  45
HIS A  94
ASN A  37
HIS A  86
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6wcf NSP3
(SARS-CoV-2)		4 / 8
VAL A  24
HIS A  45
HIS A  94
CYH A  92
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6wen NSP3
(SARS-CoV-2)		4 / 8
VAL A  24
HIS A  45
HIS A  94
ASN A  37
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6wen NSP3
(SARS-CoV-2)		4 / 8
VAL A  24
HIS A  45
HIS A  94
CYH A  92
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6wen NSP3
(SARS-CoV-2)		4 / 8
HIS A  45
HIS A  94
ASN A  37
HIS A  86
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6wey NSP3
(SARS-CoV-2)		4 / 8
HIS A 249
HIS A 298
ASN A 241
HIS A 290
1.53A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6wey NSP3
(SARS-CoV-2)		4 / 8
VAL A 228
HIS A 249
HIS A 298
ASN A 241
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6wey NSP3
(SARS-CoV-2)		4 / 8
VAL A 228
HIS A 249
HIS A 298
CYH A 296
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 8
VAL A6992
TRP A7029
HIS A7023
CYH A6823
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6wkq NSP16
(SARS-CoV-2)		4 / 8
VAL A6992
TRP A7029
HIS A7023
CYH A6823
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 7
HIS B 250
CYH B 293
LYS B 290
GLY B 247
1.49A19.01
U5P  B 401 (-4.1A)
U5P  B 401 (-4.9A)
U5P  B 401 (-2.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		4 / 7
HIS A 250
CYH A 293
LYS A 290
GLY A 247
1.49A19.01
U5P  A 401 (-4.1A)
None
U5P  A 401 (-2.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
VAL B  24
HIS B  86
CYH B  92
ASN B  54
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
VAL C  24
HIS C  45
HIS C  94
CYH C  92
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
VAL A  24
HIS A  45
HIS A  94
ASN A  37
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
HIS D  45
HIS D  94
ASN D  37
HIS D  86
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
VAL D  24
HIS D  45
HIS D  94
ASN D  37
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
VAL B  24
HIS B  45
HIS B  94
ASN B  37
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
VAL C  24
HIS C  45
HIS C  94
ASN C  37
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
VAL C 155
HIS B 119
ASP C 157
HIS B  91
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
HIS A  45
HIS A  94
ASN A  37
HIS A  86
1.47A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
VAL B  24
HIS B  45
HIS B  94
CYH B  92
1.64A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
VAL D  24
HIS D  45
HIS D  94
CYH D  92
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
VAL C  24
HIS C  86
CYH C  92
ASN C  54
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
HIS C  45
HIS C  94
ASN C  37
HIS C  86
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
VAL A  24
HIS A  45
HIS A  94
CYH A  92
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
HIS B  45
HIS B  94
ASN B  37
HIS B  86
1.49A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
VAL A 155
HIS D 119
ASP A 157
HIS D  91
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		6wq3 NSP10
(SARS-CoV-2)		4 / 7
CYH B4343
GLY B4341
ASN B4338
HIS B4336
1.76A18.65
 ZN  B4401 (-2.3A)
None
None
ZN  B4401 (-3.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		6y84 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS A  41
CYH A 145
GLY A 174
HIS A 163
1.49A19.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS A  41
CYH A 145
GLY A 174
HIS A 163
1.50A18.18
None
DMS  A 405 (-3.6A)
None
DMS  A 405 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		6ynq REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS A  41
CYH A 145
GLY A 174
HIS A 163
1.54A19.88
None
P6N  A 502 (-1.5A)
None
P6N  A 502 (-3.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ynq REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 8
VAL A  36
HIS A  80
CYH A  22
ASN A  63
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		6yt8 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
HIS A  41
CYH A 145
GLY A 174
HIS A 163
1.58A19.88
PK8  A 401 (-3.2A)
PK8  A 401 ( 1.4A)
None
DMS  A 403 (-4.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
HIS B  45
HIS B  94
ASN B  37
HIS B  86
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL B  24
HIS B  45
HIS B  94
CYH B  92
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
HIS D  45
HIS D  94
ASN D  37
HIS D  86
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL C  24
HIS C  45
HIS C  94
CYH C  92
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL E  24
HIS E  45
HIS E  94
CYH E  92
1.62A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
HIS C  45
HIS C  94
ASN C  37
HIS C  86
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
HIS E  45
HIS E  94
ASN E  37
HIS E  86
1.50A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL D  24
HIS D  45
HIS D  94
CYH D  92
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL D  24
HIS D  45
HIS D  94
ASN D  37
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL C  24
HIS C  45
HIS C  94
ASN C  37
1.45A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
HIS A  45
HIS A  94
ASN A  37
HIS A  86
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL A  24
HIS A  45
HIS A  94
ASN A  37
1.43A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL E  24
HIS E  45
HIS E  94
ASN E  37
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL B  24
HIS B  45
HIS B  94
ASN B  37
1.44A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL A  24
HIS A  45
HIS A  94
CYH A  92
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL A  24
HIS A  45
HIS A  94
ASN A  37
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL A  24
HIS A  45
HIS A  94
CYH A  92
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
HIS B  45
HIS B  94
ASN B  37
HIS B  86
1.55A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL E  24
HIS E  45
HIS E  94
CYH E  92
1.60A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL C  24
HIS C  45
HIS C  94
ASN C  37
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL D  24
HIS D  86
CYH D  92
ASN D  54
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
HIS D  45
HIS D  94
ASN D  37
HIS D  86
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
HIS E  45
HIS E  94
ASN E  37
HIS E  86
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
HIS A  45
HIS A  94
ASN A  37
HIS A  86
1.56A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL C  24
HIS C  86
CYH C  92
ASN C  54
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL B  24
HIS B  45
HIS B  94
CYH B  92
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
HIS C  45
HIS C  94
ASN C  37
HIS C  86
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL B  24
HIS B  45
HIS B  94
ASN B  37
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL D  24
HIS D  45
HIS D  94
CYH D  92
1.58A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL D  24
HIS D  45
HIS D  94
ASN D  37
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL E  24
HIS E  45
HIS E  94
ASN E  37
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL C  24
HIS C  45
HIS C  94
CYH C  92
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
HIS A  45
HIS A  94
ASN A  37
HIS A  86
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
HIS B  45
HIS B  94
ASN B  37
HIS B  86
1.48A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
HIS C  45
HIS C  94
ASN C  37
HIS C  86
1.51A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL B  24
HIS B  45
HIS B  94
CYH B  92
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL C  24
HIS C  45
HIS C  94
ASN C  37
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL B  24
HIS B  45
HIS B  94
ASN B  37
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL C  24
HIS C  45
HIS C  94
CYH C  92
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL A  24
HIS A  45
HIS A  94
ASN A  37
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_A_WJZA304_0
(BETA-LACTAMASE NDM-1)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 8
VAL A  24
HIS A  45
HIS A  94
CYH A  92
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		7bqy MAIN PROTEASE
(SARS-CoV-2)		4 / 7
HIS A  41
CYH A 145
GLY A 174
HIS A 163
1.59A19.88
None
PJE  C   5 (-1.7A)
None
PJE  C   5 (-3.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		7bqy MAIN PROTEASE
(SARS-CoV-2)		4 / 7
MET A 162
GLY A 143
ASN A  28
HIS A  41
1.73A19.88
None
PJE  C   5 (-3.1A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		7buy VIRUS MAIN PROTEASE
(SARS-CoV-2)		4 / 7
HIS A  41
CYH A 145
GLY A 174
HIS A 163
1.56A19.88
JRY  A 401 (-3.9A)
JRY  A 401 (-1.7A)
None
DMS  A 402 (-3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A5Z_C_WJZC304_0
(BETA-LACTAMASE NDM-1)		7bv1 NSP12
(SARS-CoV-2)		4 / 7
MET A 756
HIS A 599
GLY A 596
ASN A 600
1.80A14.09
None